MEI Pharma Inc.

NASDAQ: MEIP · Real-Time Price · USD
4.51
-0.17 (-3.63%)
At close: Aug 20, 2025, 9:41 AM

MEI Pharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
-2.57M -2.68M -8.01M -18.41M -9.13M -11.06M 56.37M -10.03M -15.44M 10.25M -16.62M -16.06M -20.75M -5.77M -11.88M -5.72M -31.31M -11.45M -2.09M
Depreciation & Amortization
n/a n/a 368K 125K 86K 85K 87K 98K 97K 92K 99K 85K 89K 75K 77K 70K 72K 74K 69K
Stock-Based Compensation
16K -103K -135K 397K 668K 850K 363K 299K 918K 813K 1.56M 650K 2.84M 2.32M 2.54M 2.05M 2.65M 2.61M 2.94M
Other Working Capital
-2.57M 4.28M -1.71M -12.36M 3.47M 530K -72.77M -3.78M 1.11M -20.95M -971K -177K 11.45M -8.07M 14.79M -660K 3.45M 20.51M -1.01M
Other Non-Cash Items
-710K -4.79M 223K 12.23M -364K 3.23M -2.55M 366K 860K -132K 349K 340K -12.59M -5.01M -2.59M -7.78M 215K 213K 269K
Deferred Income Tax
n/a n/a n/a n/a n/a -2.85M 2.92M n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.27M -7.08M -13.22M
Change in Working Capital
n/a 3.9M -3.9M -12.34M 5.06M -1.3M -75.69M -2.04M 1.43M -25.3M 952K -516K 13.45M -189K 4.13M 124K 3.46M 19.69M 2.92M
Operating Cash Flow
-3.27M -3.67M -11.45M -18M -2.93M -11.05M -18.49M -11.3M -12.13M -14.27M -14.78M -15.5M -16.95M -8.57M -7.72M -11.26M -15.65M 4.05M -9.11M
Capital Expenditures
n/a n/a n/a n/a n/a -7K 7K 28K 7K 63K -63K -306K -114K -51K -8K -8K n/a -56K -644K
Cash Acquisitions
n/a n/a n/a n/a n/a -24.52M n/a -28K -7K 13K n/a -20.42M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a -24.29M -9.74M -24.2M -9.67M -24.24M -33.81M -34.05M -54.49M -44.86M -113.31M -59.99M -94.99M -109.99M -160.19M -54.99M
Sales Maturities Of Investments
n/a 19.95M 14.69M 19.54M 24.42M 34.27M 29.15M 29.1M 34.27M 44.27M 47.85M 74.91M 60.13M 69.99M 74.99M 104.99M 125.37M 155.1M 60.11M
Other Investing Acitivies
n/a 500K 10K -24.52M 122K 24.52M -7K -41K -7K 10.47M 13.8M 20.42M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a 20.45M 14.7M 19.54M 122K 24.52M 4.96M 19.4M 10.03M 10.53M 13.73M 20.11M 15.16M -43.37M 14.99M 9.99M 15.39M -5.14M 4.48M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -40K n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a -11.66M -11.66M n/a n/a n/a n/a n/a n/a -60K n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -208K 11.66M n/a n/a -40K n/a n/a -40K 20K 420K -3.46M -194K 67K 126K -49K 124K
Financial Cash Flow
n/a n/a n/a -208K n/a -11.66M n/a n/a n/a n/a -40K 20K 360K 48.87M -194K 67K 126K 15K 3.26M
Net Cash Flow
-3.27M 16.79M 3.25M 1.34M -2.81M 1.8M -13.53M 8.09M -2.1M -3.74M -1.09M 4.63M -1.44M -3.07M 7.08M -1.2M -132K -1.08M -1.38M
Free Cash Flow
-3.27M -3.67M -11.45M -18M -2.93M -11.06M -18.48M -11.27M -12.12M -14.21M -14.85M -15.81M -17.07M -8.62M -7.73M -11.27M -15.65M 3.99M -9.76M